Clinical Trial Update: VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL [NA]

View source ↗

Summary

VITAL-DEP reported the completion of the depression endpoint prevention analysis within the VITAL trial and posted the results. The study evaluated Vitamin D3 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)
• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Depression, Depressive Symptoms | NA | Status: COMPLETED | Results posted: 2023-03-14